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Abstract Prolonged exposure to free fatty acids induces L-cell
cytotoxicity. We investigated whether this fatty-acid-induced
cytotoxicity is a¡ected by high glucose levels. In clonal L-cell
HIT-T15, palmitate-induced cytotoxicity was potentiated de-
pending on elevated glucose concentrations due to increased ap-
optosis without cytotoxic e¡ects of high glucose per se. This
palmitate cytotoxicity was blocked by NO synthase inhibitors,
and palmitate actually increased cellular NO production. The
potentiation of palmitate cytotoxicity under high glucose was
reversed by decreasing superoxide production, suggesting that
superoxide overproduction under high glucose enhances NO-
mediated cytotoxicity in L-cells, which may explain the mecha-
nism of synergistic deterioration of pancreatic L-cells by free
fatty acids and high glucose.
& 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Type 2 diabetes mellitus is a disease characterized by im-
paired insulin secretion and peripheral insulin resistance. Ac-
cumulated evidence suggests that hyperlipidemia enhances
L-cell dysfunction in type 2 diabetes [1]. Especially, it has
been suggested that chronically elevated concentrations of
free fatty acids (FFAs) play an important role in pancreatic
L-cell defects [2,3]. Prolonged exposure of L-cells to FFAs
causes defective insulin secretion and insulin gene expression
[4^6] and induces L-cell apoptosis [7^10]. This FFA-induced
L-cell apoptosis is observed both in vivo [7,8] and in vitro [7^
10] and has been called ‘lipoapoptosis’ [8,9].
Our initial question is whether lipoapoptosis in L-cells is
enhanced by ambient high glucose. It has been reported that
FFA-induced L-cell apoptosis is exaggerated in islets from
hyperglycemic Zucker diabetic fatty rats [7^9]. In cell culture
study, inhibition of insulin gene expression by long-term ex-
posure of L-cells to palmitate is observed only in the presence
of elevated glucose concentrations [11], suggesting that
chronic exposure to FFAs and high glucose levels synergisti-
cally impairs L-cell function. However, it is still unknown
whether fatty-acid-induced L-cell cytotoxicity is directly af-
fected by high glucose. Here, we report that L-cell cytotoxicity
caused by palmitate is signi¢cantly enhanced depending on
extracellular glucose concentrations in the L-cell line HIT-
T15.
We furthermore investigated the mechanism of palmitate-
induced apoptosis in this cell line and the mechanism of po-
tentiation of palmitate’s e¡ects by high glucose. Previously,
several mechanisms for the deleterious e¡ects of FFAs on
L-cells have been proposed, including cellular triglyceride ac-
cumulation [12^14], ceramide formation [9,10], and increased
NO formation [7]. However, it remains unclear which of these
mechanism makes the greatest contribution. We investigated
whether palmitate-induced cytotoxicity is mediated by NO
production by observing the e¡ects of simultaneous treatment
with NG-monomethyl-L-arginine (L-NMMA) and NG-nitro-L-
arginine methyl ester (L-NAME) on cell viability and measur-
ing the amount of NO metabolite production in cell culture
supernatant as an index of cellular NO production.
It has been suggested that diabetic hyperglycemia increases
the production of reactive oxygen species, especially superox-
ide, causing pathological changes in a variety of tissues includ-
ing pancreatic islets [15,16]. To test the role of high-glucose-
induced superoxide overproduction in palmitate-induced cyto-
toxicity, we treated HIT-T15 L-cells with carbonyl cyanide
m-chlorophenylhydrazone (CCCP), an uncoupler of mito-
chondrial oxidative phosphorylation, and manganese(III)te-
trakis(4-carboxyphenyl)porphyrin (MnTBAP), a superoxide
dismutase mimetic, both of which are reported to reverse
high-glucose-induced superoxide overproduction [15,17], to-
gether with palmitate.
In addition to the above, increased hexosamine £ux and
protein kinase C (PKC) activation have been implicated in
high-glucose-induced impairment of L-cell function and via-
bility [18^20]. Thus we investigated the involvement of these
pathways in the potentiation of palmitate cytotoxicity by
12.8 mM glucose, respectively by measuring the dose^re-
sponse curve of palmitate-induced cytotoxicity in the absence
and presence of glucosamine under 2.8 mM glucose, and test-
ing whether bisindolylmaleimide, a PKC inhibitor, a¡ects pal-
mitate-induced cytotoxicity.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), RPMI 1640 me-
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dium, fetal bovine serum, and antibiotics were from Gibco (Grand
Island, NY, USA). L-NMMA and L-NAME were from Dojindo
(Kumamoto, Japan). MnTBAP was from Calbiochem (San Diego,
CA, USA). All other chemicals were from Sigma (St. Louis, MO,
USA).
2.2. Preparation of palmitate solution
A concentrated stock solution of palmitate was prepared by dis-
solving powder in ethanol:H2O (1:1) at 50‡C. This stock solution was
added to RPMI 1640 (no glucose) supplemented with 2.8 mM glucose
and 1% fatty-acid-free bovine serum albumin (BSA) and incubated at
37‡C with gentle shaking to allow complex formation of BSA and
palmitate. After ¢ltration, the concentration of albumin-bound palmi-
tate was measured with the NEFA-C kit from Wako (Osaka, Japan).
2.3. L-Cell culture and treatment
HIT-T15 cells, a hamster L-cell line, were routinely maintained in
RPMI 1640 (no glucose) supplemented with 2.8 mM glucose, 10%
fetal bovine serum, 10 000 U/ml penicillin, 10 mg/ml streptomycin
and 25 Wg/ml amphotericin B in a humidi¢ed incubator with 5%
CO2 at 37‡C. For all assays, cells were inoculated into 96-well plates
at 3U104/well and cultured for several days. Each well was washed
with 150 Wl of RPMI 1640 (no glucose) twice, and then 100 Wl of
RPMI 1640 supplemented with 1% fatty-acid-free BSA including var-
ious concentrations of palmitate and glucose was added. For glucos-
amine treatment, 100 Wl of RPMI 1640 supplemented with 1% fatty-
acid-free BSA including various concentrations of palmitate and glu-
cosamine was added. For L-NMMA, L-NAME, CCCP, MnTBAP,
and bisindolylmaleimide treatment, 1 Wl of various concentrations of
each compound was added directly from each stock solution to give
¢nal concentrations. One microliter of the solvent used for the prep-
aration of each compound stock solution was added to control wells.
Treated cells were further incubated in the incubator above at 37‡C
for 24 h.
2.4. MTT assay
A solution of 500 Wg/ml of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphe-
nyltetrazolium bromide (MTT) was prepared in DMEM (low glucose)
before use. The medium was aspirated, 100 Wl of MTT solution
added, and incubated at 37‡C for 1 h. The medium was removed
and 100 Wl of dimethyl sulfoxide added to lyse the cells. The absor-
bance at 490 nm with 650 nm of reference wavelength was measured
using a SpectraMax microplate reader from Molecular Devices (Osa-
ka, Japan).
2.5. Measurement of DNA fragmentation
For quantitative determination of apoptotic DNA fragmentation,
cytoplasmic histone-associated DNA fragments were measured with
the Cell Death Detection ELISA kit (Roche) according to the manu-
facturer’s instructions. After the medium was removed, cells were in-
cubated with lysis bu¡er at 4‡C for 30 min. The lysates were centri-
fuged at 20 000Ug for 10 min and the obtained supernatant was
collected. After 1:10 dilution, 100 Wl of each sample was used for
the detection.
2.6. Nitrate/nitrite determination
Total nitrate and nitrite formation in cell culture supernatants was
measured as an indication of NO production. After palmitate treat-
ment for 24 h, 5 Wl of the supernatant was taken and the total
amounts of nitrate and nitrite in each sample determined with the
Nitrate/Nitrite Fluorometric Assay kit from Cayman (Denver, CO,
USA) according to the manufacturer’s instructions.
2.7. Statistical analysis
Results are expressed as the meanSS.E.M. The signi¢cance of the
di¡erence between two groups was assessed by Student’s unpaired
t-test. P values of less than 5% were considered statistically signi¢cant.
C
Fig. 1. Potentiation of palmitate-induced cytotoxicity and apoptosis
by high glucose levels. A: HIT-T15 L-cells were incubated with the
indicated concentrations of palmitate for 24 h under 2.8 mM or
12.8 mM glucose. Cell viability was measured by the MTT assay
and represented as percent of control under each glucose concentra-
tion. In the control condition, cell viability was measured after 24 h
incubation in the absence of palmitate under each glucose concen-
tration. Each bar represents the mean of six replicates S S.E.M.
**P6 0.005 versus cell viability in the treatment of the same con-
centration of palmitate under 2.8 mM glucose. B: HIT-T15 L-cells
were incubated in the absence (control) or presence of 0.5 mM pal-
mitate for 24 h under each indicated glucose concentration and cell
viability was measured by the MTT assay. Cell viability in the treat-
ment of palmitate is represented as percent of control under each
glucose concentration. Each bar represents the mean of six replica-
tes S S.E.M. *P6 0.05 versus cell viability under 2.8 mM glucose.
C: HIT-T15 L-cells were incubated in the absence (control) or pres-
ence of 0.5 mM palmitate for 24 h under 2.8 mM or 12.8 mM glu-
cose. Cytosol fractions were prepared and the amount of cytosolic
DNA-associated histone was measured with the Cell Death Detec-
tion ELISA kit. Each bar represents a relative factor versus the
control value under 2.8 mM glucose as the mean of four replica-
tes S S.E.M. **P6 0.005 between 2.8 mM and 12.8 mM glucose
conditions in the presence of palmitate.
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3. Results
In HIT-T15 L-cells, palmitate induced cytotoxicity in a
dose-dependent manner between 0.5 and 1.5 mM after 24 h
treatment. This cytotoxic e¡ect of palmitate was signi¢cantly
potentiated at all concentrations tested when ambient glucose
concentration was 12.8 mM versus 2.8 mM (Fig. 1A). Cell
viability was not a¡ected solely by increasing glucose concen-
tration from 2.8 mM to 12.8 mM in the absence of palmitate
(data not shown), therefore 12.8 mM glucose per se does not
appear to have any negative e¡ects on cell viability except for
enhancing palmitate-induced cytotoxicity. This potentiation of
palmitate-induced cytotoxicity was dependent on glucose con-
centration between 2.8 and 12.8 mM (Fig. 1B).
Palmitate-induced cytotoxicity in HIT-T15 L-cells was
caused by cell death due to apoptosis characterized by
DNA fragmentation (Fig. 1C). In the absence of palmitate,
increasing the glucose concentration from 2.8 mM to 12.8
mM did not increase DNA fragmentation, indicating that at
concentrations up to 12.8 mM, glucose per se does not in-
crease apoptosis for 24 h in HIT-T15 L-cells. However, pal-
mitate-induced DNA fragmentation was signi¢cantly in-
creased in the presence of 12.8 mM glucose versus that
observed with 2.8 mM glucose (Fig. 1C). Therefore palmi-
tate-induced apoptosis was accelerated by 12.8 mM glucose
in these cells.
Palmitate-induced cytotoxicity in the presence of both 2.8
and 12.8 mM glucose was signi¢cantly inhibited by simulta-
neous treatment with L-NMMA and L-NAME (Fig. 2). Fur-
thermore, palmitate treatment signi¢cantly increased the
amount of nitrate/nitrite in the supernatant (Fig. 3). However,
no di¡erence was observed between nitrate/nitrite in superna-
tant under 12.8 mM glucose versus 2.8 mM glucose (Fig. 3),
indicating that the potentiation of the cytotoxic e¡ect of pal-
mitate under 12.8 mM glucose cannot be explained solely by
increased NO production.
In the experiments investigating the e¡ect of treating HIT-
T15 L-cells with CCCP and MnTBAP together with palmi-
tate, palmitate-induced cytotoxicity was signi¢cantly dimin-
ished only under the 12.8 mM glucose condition, suggesting
that superoxide is involved in palmitate-induced cytotoxicity
when glucose concentration is elevated (Fig. 4).
Glucosamine did not mimic the e¡ect of high glucose on
palmitate-induced cytotoxicity up to 10 mM (Fig. 5A), and
bisindolylmaleimide did not reverse enhanced palmitate-in-
duced cytotoxicity under 12.8 mM glucose (Fig. 5B).
4. Discussion
Our data clearly show that L-cell cytotoxicity by palmitate
is potentiated under high glucose conditions in HIT-T15
L-cells. This indicates that exposure to FFAs and high glucose
synergistically damages L-cells in terms of induction of apo-
ptosis. In addition, palmitate-induced cytotoxicity was en-
hanced by glucose depending on glucose concentration be-
tween 2.8 and 12.8 mM, suggesting that the degree of
lipoapoptosis may be tightly modulated by glucose concentra-
tions.
Our results do not support the participation of increased
hexosamine £ux or PKC activation in the enhancement of
palmitate-induced cytotoxicity when glucose concentration is
Fig. 3. NO production by palmitate treatment in HIT-T15 L-cells.
HIT-T15 L-cells were incubated in the absence (control) or presence
of 0.5 mM palmitate for 24 h under 2.8 mM or 12.8 mM glucose.
Cell culture supernatant in each condition was collected and total
amounts of nitrate and nitrite contained in each supernatant were
measured with the Nitrate/Nitrite Fluorometric Assay kit. Each bar
represents the mean of four replicatesS S.E.M. *P6 0.05 between
control and palmitate treatment under each glucose concentration.
Fig. 2. Blockade of palmitate-induced cytotoxicity by NO synthase
inhibitors. A: HIT-T15 L-cells were incubated without palmitate
(control), with 0.5 mM palmitate, or with 0.5 mM palmitate+2 mM
L-NMMA for 24 h under 2.8 mM or 12.8 mM glucose. Cell viabil-
ity was measured by the MTT assay and is represented as percent
of control under each glucose concentration. Each bar represents
the mean of six replicates S S.E.M. **P6 0.005 between treatment
with palmitate alone and palmitate+L-NMMA. B: HIT-T15 L-cells
were incubated without palmitate (control), with 0.5 mM palmitate,
or with 0.5 mM palmitate+2 mM L-NAME for 24 h under 2.8 mM
or 12.8 mM glucose. Cell viability was measured by the MTT assay
and is represented as percent of control under each glucose concen-
tration. Each bar represents the mean of six replicates S S.E.M.
**P6 0.005 between treatment with palmitate alone and palmi-
tate+L-NAME.
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elevated. However, palmitate-induced cytotoxicity was
blocked by treatment with L-NMMA and L-NAME, both
of which are inhibitors of NO synthase. NO is a widely known
apoptosis mediator [21] and pancreatic L-cells are susceptible
to NO-induced apoptosis [22,23]. In our study, palmitate
treatment actually elevated NO production in HIT-T15
L-cells, as indicated by increased amounts of NO metabolites
in supernatant, therefore it seems likely that palmitate leads to
cell death by increasing NO levels in this cell line. Although it
has been reported that FFAs induce the expression of induc-
ible NO synthase (iNOS) in isolated islets [7], palmitate-in-
duced cytotoxicity in HIT-T15 L-cells was not inhibited by
the treatment with aminoguanidine, an inhibitor of iNOS
(data not shown), and so the contribution of iNOS to palmi-
tate-induced cytotoxicity in this cell line is unclear. However,
it has been reported that constitutive NO synthase (cNOS)
protein is palmitoylated and cellular distribution of this mol-
ecule is controlled by this modi¢cation [24]. Therefore palmi-
tate might increase cellular NO production by a¡ecting cNOS.
In addition, involvement of NO in FFA-induced L-cell death
is still controversial [10,25]. In our study, NOS inhibitors did
not inhibit palmitate-induced cytotoxicity completely. There-
fore some other mechanisms may be implicated in palmitate-
induced cytotoxicity.
NO-mediated cell injury is considered to be mostly due to
the generation of peroxynitrite, a reactive oxidant produced
from NO and superoxide [26,27]. Peroxynitrite is a potent
initiator of DNA breakage, leading to cell apoptosis [28]. In
the present study, we demonstrated that palmitate-induced
NO-mediated cytotoxicity is signi¢cantly potentiated when
ambient glucose concentration is elevated although high glu-
cose per se did not increase cell apoptosis at the concentra-
tions and incubation period we used. Under high glucose con-
ditions, the production of superoxide is elevated mainly
because of increased glucose oxidation and following increase
of superoxide production through the mitochondrial electron
transport chain [15]. Superoxide overproduction accelerates
the formation of peroxynitrite in the presence of NO and
exaggerates the cytotoxic e¡ects of NO [29,30]. Our data
show that two distinct pharmacological applications to de-
crease superoxide, abolition of mitochondrial membrane pro-
ton gradient by an uncoupler of oxidative phosphorylation
Fig. 4. Reversal of high-glucose-induced potentiation of palmitate
cytotoxicity by decreasing superoxide. A: HIT-T15 L-cells were in-
cubated without palmitate (control), with 0.5 mM palmitate, or
with 0.5 mM palmitate+3 WM CCCP for 24 h under 2.8 mM or
12.8 mM glucose. Cell viability was measured by the MTT assay
and is represented as percent of control under each glucose concen-
tration. Each bar represents the mean of six replicates S S.E.M.
*P6 0.05 between treatment with palmitate alone and palmita-
te+CCCP. B: HIT-T15 L-cells were incubated without palmitate
(control), with 0.5 mM palmitate, or with 0.5 mM palmitate+100
WM MnTBAP for 24 h under 2.8 mM or 12.8 mM glucose. Cell vi-
ability was measured by the MTT assay and is represented as per-
cent of control under each glucose concentration. Each bar repre-
sents the mean of six replicates S S.E.M. *P6 0.05 between
treatment with palmitate alone and palmitate+MnTBAP.
Fig. 5. No participation of increased hexosamine £ux or PKC acti-
vation in high-glucose-induced potentiation of palmitate cytotoxicity
was observed. A: HIT-T15.20 L-cells were incubated with the indi-
cated concentrations of palmitate for 24 h under 2.8 mM glucose
supplemented with 0, 5, or 10 mM glucosamine (GlcN). Cell viabil-
ity was measured by the MTT assay and is represented as percent
of control (no palmitate). Each bar represents the mean of six repli-
cates S S.E.M. B: HIT-T15 cells were incubated without palmitate
(control), with 0.5 mM palmitate, or with 0.5 mM palmitate+1 WM
bisindolylmaleimide (BIM) for 24 h under 12.8 mM glucose. Cell vi-
ability was measured by the MTT assay and is represented as per-
cent of control. Each bar represents the mean of six replicatesS
S.E.M.
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and direct elimination of superoxide anion by a superoxide
dismutase mimetic, signi¢cantly lessen palmitate-induced cy-
totoxicity only when the glucose concentration is elevated.
These ¢ndings raise the possibility that cytotoxicity of NO
generated by palmitate treatment is enhanced through in-
creased peroxynitrite formation caused by superoxide over-
production under high glucose conditions. This potentiation
of palmitate-induced NO-mediated L-cell toxicity by high-glu-
cose-induced superoxide overproduction may explain the
mechanism of synergistic deterioration of pancreatic L-cells
by FFAs and high glucose.
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